EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 66 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,695,000 | -38.4% | 449,338 | -57.6% | 0.60% | -56.0% |
| Q3 2019 | $10,865,000 | -9.8% | 1,060,043 | -6.7% | 1.37% | +12.7% |
| Q2 2019 | $12,042,000 | -46.0% | 1,136,043 | -28.8% | 1.22% | -40.8% |
| Q1 2019 | $22,307,000 | +37.6% | 1,595,643 | 0.0% | 2.06% | +26.8% |
| Q4 2018 | $16,212,000 | +30.0% | 1,595,643 | +53.5% | 1.62% | +44.3% |
| Q3 2018 | $12,474,000 | -1.6% | 1,039,500 | 0.0% | 1.12% | -6.9% |
| Q2 2018 | $12,682,000 | +4413.2% | 1,039,500 | +7225.6% | 1.21% | +987.4% |
| Q2 2016 | $281,000 | -91.2% | 14,190 | -92.5% | 0.11% | -90.0% |
| Q1 2016 | $3,179,000 | – | 189,545 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |